miR-486-5p inhibits cell proliferation and invasion through repressing GAB2 in non-small cell lung cancer

被引:34
作者
Yu, Sunfeng [1 ]
Geng, Shuang [1 ]
Hu, Yi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Dept Resp Med, 26 Shengli St, Wuhan 430014, Hubei, Peoples R China
关键词
miR-486-5p; non-small cell lung cancer; invasion; proliferation; GAB2; DOWN-REGULATION; PROGRESSION; SUPPRESSES; EXPRESSION; MIGRATION; METASTASIS; MICRORNAS; NSCLC;
D O I
10.3892/ol.2018.9053
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have reported that cell metastasis is the main reason for the high mortality of non-small cell lung cancer (NSCLC). Many miRNAs have been identified to be involved in the development of NSCLC. In this study, we explored the effect of miR-486-5p and GAB2 on cell proliferation and invasion in NSCLC. First, miR-486-5p and GAB2 expression levels were detected in NSCLC through quantitative RT-qPCR, and downregulation of miR-486-5p and upregulation of GAB2 were both identified in NSCLC. Then MTT and Transwell analysis were performed to confirm the functions of miR-486-5p and GAB2 for cell proliferation and invasion in NSCLC. Moreover, miR-486-5p overexpression was found to inhibit proliferation and invasion by suppressing GAB2 in NSCLC cells. Besides, miR-486-5p overexpression lessened GAB2 expression level in NSCLC, while miR-486-5p knockout enhanced GAB2 expression level. Additionally, miR-486-5p was identified to directly target GAB2 through dual luciferase reporter assay. The silence of GAB2 was found to inhibit proliferation and invasion of NSCLC cells. Collectively, miR-486-5p contributed to inhibiting proliferation and invasion of NSCLC cells through regulating GAB2, and miR-486-5p/GAB2 axis may provide a breakthrough for diagnosing NSCLC.
引用
收藏
页码:3525 / 3530
页数:6
相关论文
共 33 条
[1]   MicroRNA-486 dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms [J].
Alexander, Matthew S. ;
Carlos Casar, Juan ;
Motohashi, Norio ;
Vieira, Natassia M. ;
Eisenberg, Iris ;
Marshall, Jamie L. ;
Gasperini, Molly J. ;
Lek, Angela ;
Myers, Jennifer A. ;
Estrella, Elicia A. ;
Kang, Peter B. ;
Shapiro, Frederic ;
Rahimov, Fedik ;
Kawahara, Genri ;
Widrick, Jeffrey J. ;
Kunkel, Louis M. .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (06) :2651-2667
[2]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   Structure and function of Gab2 and its role in cancer (Review) [J].
Ding, Chen-Bo ;
Yu, Wei-Na ;
Feng, Ji-Hong ;
Luo, Jun-Min .
MOLECULAR MEDICINE REPORTS, 2015, 12 (03) :4007-4014
[5]   miR-205 as a biological marker in non-small cell lung cancer [J].
Duan, Baoqi ;
Guo, Tao ;
Sun, Haoliang ;
Cai, Rui ;
Rui, Qinglin ;
Xi, Zhaoqing .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 91 :823-830
[6]   Classification of Non-small Cell Lung Carcinoma in Transthoracic Needle Specimens Using MicroRNA Expression Profiling [J].
Fassina, Ambrogio ;
Cappellesso, Rocco ;
Fassan, Matteo .
CHEST, 2011, 140 (05) :1305-1311
[7]  
Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
[8]   microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2) [J].
Gu, Dong-hua ;
Mao, Jia-Hui ;
Pan, Xiao-dong ;
Zhu, Hua ;
Chen, Xinfeng ;
Zheng, Bing ;
Shan, Yuxi .
ONCOTARGET, 2017, 8 (16) :26334-26343
[9]  
Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
[10]   miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1 [J].
Ke, Yang ;
Zhao, Weiyong ;
Xiong, Jie ;
Cao, Rubo .
BIOCHEMISTRY RESEARCH INTERNATIONAL, 2013, 2013